Reducing the rate of nosocomially transmitted respiratory syncytial virus

Lynne V. Karanfil, Martha Conlon, Kelly Lykens, Carolyn F. Masters, Michael Forman, Mary Elizabeth Griffith, Timothy R. Townsend, Trish M. Perl

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Background: A large number (17) of nosocomial respiratory syncytial virus cases led to the development of control measures to prevent transmission of respiratory syncytial virus (RSV) within the Johns Hopkins Hospital's Children's Center. Methods: The control plan is based on a 2- stage process. In stage 1, the staff are notified that RSV is in the community, and information is distributed through a communication tree. Stage 2 requires that nasopharyngeal aspirates be obtained from all children <3 years of age who have respiratory symptoms. The aspirates are tested directly for RSV antigen and cultured for RSV. The children are placed on pediatric droplet precautions pending those results. Results: The proportion of nosocomial RSV cases dropped from 16.5% before the use of RSV control measures to 7.2% after the initiation of the control program. A case of RSV identified in the hospital was 2.6 times more likely to be nosocomially acquired before the intervention compared with after the intervention. Approximately 14 cases of RSV are prevented each year, which results in a savings of 56 hospital-days and more than $84,000 in direct hospital-related charges alone. Conclusions: The nosocomial spread of RSV can be reduced by a specific and feasible control plan that includes early identification and rapid isolation of potential RSV cases.

Original languageEnglish (US)
Pages (from-to)91-96
Number of pages6
JournalAmerican Journal of Infection Control
Volume27
Issue number2
DOIs
StatePublished - Jan 1 1999

Fingerprint

Respiratory Syncytial Viruses
Hospital Charges
Communication
Pediatrics
Antigens

ASJC Scopus subject areas

  • Epidemiology
  • Health Policy
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Cite this

Reducing the rate of nosocomially transmitted respiratory syncytial virus. / Karanfil, Lynne V.; Conlon, Martha; Lykens, Kelly; Masters, Carolyn F.; Forman, Michael; Griffith, Mary Elizabeth; Townsend, Timothy R.; Perl, Trish M.

In: American Journal of Infection Control, Vol. 27, No. 2, 01.01.1999, p. 91-96.

Research output: Contribution to journalArticle

Karanfil, LV, Conlon, M, Lykens, K, Masters, CF, Forman, M, Griffith, ME, Townsend, TR & Perl, TM 1999, 'Reducing the rate of nosocomially transmitted respiratory syncytial virus', American Journal of Infection Control, vol. 27, no. 2, pp. 91-96. https://doi.org/10.1016/S0196-6553(99)70087-8
Karanfil, Lynne V. ; Conlon, Martha ; Lykens, Kelly ; Masters, Carolyn F. ; Forman, Michael ; Griffith, Mary Elizabeth ; Townsend, Timothy R. ; Perl, Trish M. / Reducing the rate of nosocomially transmitted respiratory syncytial virus. In: American Journal of Infection Control. 1999 ; Vol. 27, No. 2. pp. 91-96.
@article{17c97903c7d84d3fb4335cccabba21c7,
title = "Reducing the rate of nosocomially transmitted respiratory syncytial virus",
abstract = "Background: A large number (17) of nosocomial respiratory syncytial virus cases led to the development of control measures to prevent transmission of respiratory syncytial virus (RSV) within the Johns Hopkins Hospital's Children's Center. Methods: The control plan is based on a 2- stage process. In stage 1, the staff are notified that RSV is in the community, and information is distributed through a communication tree. Stage 2 requires that nasopharyngeal aspirates be obtained from all children <3 years of age who have respiratory symptoms. The aspirates are tested directly for RSV antigen and cultured for RSV. The children are placed on pediatric droplet precautions pending those results. Results: The proportion of nosocomial RSV cases dropped from 16.5{\%} before the use of RSV control measures to 7.2{\%} after the initiation of the control program. A case of RSV identified in the hospital was 2.6 times more likely to be nosocomially acquired before the intervention compared with after the intervention. Approximately 14 cases of RSV are prevented each year, which results in a savings of 56 hospital-days and more than $84,000 in direct hospital-related charges alone. Conclusions: The nosocomial spread of RSV can be reduced by a specific and feasible control plan that includes early identification and rapid isolation of potential RSV cases.",
author = "Karanfil, {Lynne V.} and Martha Conlon and Kelly Lykens and Masters, {Carolyn F.} and Michael Forman and Griffith, {Mary Elizabeth} and Townsend, {Timothy R.} and Perl, {Trish M.}",
year = "1999",
month = "1",
day = "1",
doi = "10.1016/S0196-6553(99)70087-8",
language = "English (US)",
volume = "27",
pages = "91--96",
journal = "American Journal of Infection Control",
issn = "0196-6553",
publisher = "Mosby Inc.",
number = "2",

}

TY - JOUR

T1 - Reducing the rate of nosocomially transmitted respiratory syncytial virus

AU - Karanfil, Lynne V.

AU - Conlon, Martha

AU - Lykens, Kelly

AU - Masters, Carolyn F.

AU - Forman, Michael

AU - Griffith, Mary Elizabeth

AU - Townsend, Timothy R.

AU - Perl, Trish M.

PY - 1999/1/1

Y1 - 1999/1/1

N2 - Background: A large number (17) of nosocomial respiratory syncytial virus cases led to the development of control measures to prevent transmission of respiratory syncytial virus (RSV) within the Johns Hopkins Hospital's Children's Center. Methods: The control plan is based on a 2- stage process. In stage 1, the staff are notified that RSV is in the community, and information is distributed through a communication tree. Stage 2 requires that nasopharyngeal aspirates be obtained from all children <3 years of age who have respiratory symptoms. The aspirates are tested directly for RSV antigen and cultured for RSV. The children are placed on pediatric droplet precautions pending those results. Results: The proportion of nosocomial RSV cases dropped from 16.5% before the use of RSV control measures to 7.2% after the initiation of the control program. A case of RSV identified in the hospital was 2.6 times more likely to be nosocomially acquired before the intervention compared with after the intervention. Approximately 14 cases of RSV are prevented each year, which results in a savings of 56 hospital-days and more than $84,000 in direct hospital-related charges alone. Conclusions: The nosocomial spread of RSV can be reduced by a specific and feasible control plan that includes early identification and rapid isolation of potential RSV cases.

AB - Background: A large number (17) of nosocomial respiratory syncytial virus cases led to the development of control measures to prevent transmission of respiratory syncytial virus (RSV) within the Johns Hopkins Hospital's Children's Center. Methods: The control plan is based on a 2- stage process. In stage 1, the staff are notified that RSV is in the community, and information is distributed through a communication tree. Stage 2 requires that nasopharyngeal aspirates be obtained from all children <3 years of age who have respiratory symptoms. The aspirates are tested directly for RSV antigen and cultured for RSV. The children are placed on pediatric droplet precautions pending those results. Results: The proportion of nosocomial RSV cases dropped from 16.5% before the use of RSV control measures to 7.2% after the initiation of the control program. A case of RSV identified in the hospital was 2.6 times more likely to be nosocomially acquired before the intervention compared with after the intervention. Approximately 14 cases of RSV are prevented each year, which results in a savings of 56 hospital-days and more than $84,000 in direct hospital-related charges alone. Conclusions: The nosocomial spread of RSV can be reduced by a specific and feasible control plan that includes early identification and rapid isolation of potential RSV cases.

UR - http://www.scopus.com/inward/record.url?scp=0032936028&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032936028&partnerID=8YFLogxK

U2 - 10.1016/S0196-6553(99)70087-8

DO - 10.1016/S0196-6553(99)70087-8

M3 - Article

C2 - 10196485

AN - SCOPUS:0032936028

VL - 27

SP - 91

EP - 96

JO - American Journal of Infection Control

JF - American Journal of Infection Control

SN - 0196-6553

IS - 2

ER -